/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | BNGOBionano Genomics, In |
|---|---|
| Last close | $1.16 |
| Change % | +2.65% |
| Market cap | $14M |
| P/E | — |
| Revenue | $29M |
| Rev growth (YoY) | -7.4% |
| Net income | $-26395000 |
| Net margin | -92.6% |
| EPS (diluted) | $-4.85 |
| Piotroski F-ScoreUNVALIDATED | 3 |
| Altman Z-ScoreUNVALIDATED | -14.15 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 11-07 → 11-17 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.